Characterization of an envelope mutant of HIV-1 that interferes with viral infectivity

Virology

Volumn 226, Issue 2, 1996, Pages 260-268

  Chen, Steve S L ^a,b   Ferrante, Anthony A ^a   Terwilliger, Ernest F ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN;

ARTICLE; DNA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOBLOTTING; MUTATION; NONHUMAN; PRIORITY JOURNAL; VIRUS REPLICATION;

EID: 0030589456     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0654     Document Type: Article

References (43)

1. Amaya, E., Musci, T. J., and Kirschner, M. W. (1991). Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopus embryos. Cell 66, 257-270.
2. Bernstein, H. B., Tucker, S. P., Kar, S. R., McPherson, S. A., McPherson, D. T., Dubay, J. W., Lebowitz, J., Compans, R. W., and Hunter, E. (1995). Oligomerization of the hydrophobic heptad repeat of gp41. J. Virol. 69, 2745-2750.
3. Bukrinsky, M. I., Haggerty, S., Dempsey, M. P., Sharova, N., Adzhubel, A., Spitz, L., Lewis, P., Goldfarb, D., Emerman, M., and Stevenson, M. (1993a). A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature (London) 365, 666-669.
4. Bukrinsky, M. I., Sharova, N., McDonald, T. L., Pushkarskaya, T., Tarpley, W. G., and Stevenson, M. (1993b). Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc. Natl. Acad. Sci. USA 90, 6125-6129.
5. Chen, S.-L. (1994). Functional role of the zipper motif region of human immunodeficiency virus type 1 transmembrane protein gp41. J. Virol. 68, 2002-2010.
6. Chen, S.-L., Lee, C.-N., Lee, W.-R., McIntosh, K., and Lee, T.-H. (1993). Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein. J. Virol. 67, 3615-3619.
7. Doms, R. W., Earl, P. L., Chakrabarti, S., and Moss, B. (1990). Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus env proteins possess a functionally conserved assembly domain. J. Virol. 64, 3537-3540.
8. Dorfman, T., Mannano, F., Haseltine, W. A., and Gottlinger, H. G. (1994). Role of matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 68, 1689-1696.
9. Dubay, J. W., Roberts, S., Hahn, B. H., and Hunter, E. (1992). Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity. J. Virol. 66, 6016-6025.
10. Earl, P. L., Koenig, S., and Moss, B. (1991). Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: Analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses. J. Virol. 65, 31-41.
11. Earl, P. L., Doms, R. W., and Moss, B. (1990). Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein. Proc. Natl. Acad. Sci. USA 87, 648-652.
12. Earl, P. L., and Moss, B. (1993). Mutational analysis of the assembly domain of the HIV-1 envelope glycoprotein. AIDS Res. Hum. Retroviruses 9, 589-594.
13. Fisher, A. G., Collalti, E., Ratner, L., Gallo, R. C., and Wong-Staal, F. (1985). A molecular clone of HTLV-III with biological activity. Nature (London) 316, 262-265.
14. Fisher, A. G., Ratner, L., Mitsuya, H., Marselle, L. M., Harper, M. E., Broder, S., Gallo, R. C., and Wong-Staal, F. (1986). Infectious mutants of HTLV-III with changes in the 3′ region and markedly reduced cytopathic effects. Science 233, 655-659.
15. Freed, E. O., Delwart, E. L., Buchschacher, G. L., Jr., and Panganiban, A. T. (1992). A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. Proc. Natl. Acad. Sci. USA 89, 70-74.
16. Freed, E. O., and Martin, M. A. (1995). Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J. Virol. 69, 1984-1989.
17. Gabuzda, D. H., Lever, A., Terwilliger, E., and Sodroski, J. (1992). Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 66, 3306-3315.
18. Gelderblom, H. R., Ozel, M., Hausmann, E. H., Winkel, T., Pauli, G., and Koch, M. A. (1988). Fine structure of human immunodeficiency virus (HIV), immunolocalization of structural proteins and virus-cell relation. Micron Microsc. Acta 19, 41-60.
19. Gottlinger, H. G., Dorfman, T., Cohen, E. A., and Haseltine, W. A. (1993). VPU protein of HIV-1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proc. Natl. Acad. Sci. USA 90, 7381-7385.
20. Green, M., Ishino, M., and Loewenstein, P. M. (1989). Mutational analysis of HIV-1 Tat minimal domain peptides: Identification of transdominant mutants that suppress HIV-LTR-driven gene expression. Cell 58, 215-223.
21. Grief, C., Hockley, D. J., Fromholc, C. E., and Kitchin, P. A. (1989). The morphology of simian immunodeficiency virus as shown by negative staining electron microscopy. J. Gen. Virol. 70, 2215-2219.
22. Helseth, E., Kowalski, M., Gabuzda, D., Olshevsky, U., Haseltine, W., and Sodroski, J. (1990). Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants. J. Virol. 64, 2416-2420.
23. Kowalski, M., Potz, J., Basiripour, L., Dorfman, T., Goh, W. C., Terwilliger, E., Dayton, A., Rosen, C., Haseltine, W., and Sodroski, J. (1987). Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 237, 1351-1355.
24. Lee, S.-J., Hu, W., Fisher, A. G., Looney, D. J., Kao, V. F., Mitsuya, H., Ratner, L., and Wong-Staal, F. (1989). Role of the carboxy-terminal portion of the HIV-1 transmembrane protein in viral transmission and cytopathogenicity. AIDS Res. Hum. Retroviruses 5, 441-449.
25. Lodge, R., Gottlinger, H. G., Gabuzda, D., Cohen, E. A., and Lemay, G. (1994). The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells. J. Virol. 68, 4857-4861.
26. Malim, M. H., Bohnlein, S., Hauber, J., and Cullen, B. R. (1989). Functional dissection of the HIV-1 Rev trans-activator - Derivation of a transdominant repressor of Rev function. Cell 58, 205-214.
27. Mannano, F., Kondo, E., Sodroski, J., Bukovsky, A., and Gottlinger, H. G. (1995). Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J. Virol. 69, 3824-3830.
28. Pinter, A., Honnen, W. J., Tilley, S. A., Bona, C., Zaghouani, H., Gorny, M. K., and Zolla-Pazner, S. (1989). Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1. J. Virol. 63, 2674-2679.
29. Poumbourios, P., Ahmar, W. E., McPhee, D. A., and Kemp, B. E. (1995). Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure. J. Virol. 69, 1209-1218.
30. Rey, M.-A., Krust, B., Laurent, A. G., Montagnier, L., and Hovanessian, A. G. (1989). Characterization of human immunodeficiency virus type 2 envelope glycoproteins: dimerization of the glycoprotein precursor during processing. J. Virol. 63, 647-658.
31. Rey, M.-A., Laurent, A. G., McClure, J., Krust, B., Montagnier, L., and Hovanessian, A. G. (1990). Transmembrane envelope glycoproteins of human immunodeficiency virus type 2 and simian immunodeficiency virus SIV-mac exist as homodimers. J. Virol. 64, 922-926.
32. Rekosh, D., Nygren, A., Flodby, P., Hammarskjold, M.-L., and Wigzell, H. (1988). Coexpression of human immunodeficiency virus envelope proteins and tat from a single simian virus 40 late replacement vector. Proc. Natl. Acad. Sci. USA 85, 334-338.
33. Rosen, C. A., Sodroski, J. G., Campbell, K., and Haseltine, W. A. (1986). Construction of recombinant retroviruses that express the human T cell leukemia virus type II and human T cell leukemia virus type III transactivator. J. Virol. 57, 379-384.
34. Sodroski, J., Goh, W. C., Rosen, C., Campbell, K., and Haseltine, W. A. (1986). Role of the HTLV-III/LAV envelope in syncytia formation and cytopathicity. Nature (London) 322, 470-474.
35. Steffy, K. R., and Wong-Staal, F. (1993). Transdominant inhibition of wild-type human immunodeficiency virus type 2 replication by an envelope deletion mutant. J. Virol. 67, 1854-1859.
36. Terwilliger, E. F., Godin, B., Sodroski, J. G., and Haseltine, W. A. (1989). Construction and use of a replication-competent human immunodeficiency virus (HIV-1) that expresses the chloramphenicol acetyltransferase enzyme. Proc. Natl. Acad. Sci. USA 86, 3857-3861.
37. Terwilliger, E., Sodroski, J. G., Rosen, C. A., and Haseltine, W. A. (1986). Effects of mutations within the 3′ orf open reading frame region of human T-cell lymphotropic virus type III(HTLV-III/LAV) on replication and cytopathogenicity. J. Virol. 60, 754-760.
38. Thomas, D. J., Wall, J. S., Hainfeld, J. F., Kaczorek, M., Booy, F. P., Trus, B. L., Eiserling, F. A., and Steven, A. C. (1991). gp160, the envelope glycoprotein of human immunodeficiency virus type 1, is a dimer of 125-kilodalton subunits stabilized through interactions between their gp41 domains. J. Virol. 65, 3797-3803.
39. Trono, D., Feinberg, M. B., and Baltimore, D. (1989). HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus. Cell 59, 113-120.
40. Ueno, H., Colbert, H., Escobedo, J. A., and Williams, L. T. (1991). Inhibition of PDGF b receptor signal transduction by coexpression of a truncated receptor. Science 252, 844-848.
41. Wilk, T., Pfeiffer, T., and Bosch, V. (1992). Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the c-terminal tail of the env gene product. Virology 198, 167-177.
42. Yu, X., Yuan, X., Matsuda, Z., Lee, T.-H., and Essex, M. (1992). The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J. Virol. 66, 4966-4971.
43. Yu, X., Yuan, X., McLane, M. F., Lee, T.-H., and Essex, M. (1993). Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of the Env proteins into mature virions. J. Virol. 67, 213-221.